BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31529191)

  • 1. CD44 splice variant (CD44v3) promotes progression of urothelial carcinoma of bladder through Akt/ERK/STAT3 pathways: novel therapeutic approach.
    Anand V; Khandelwal M; Appunni S; Gupta N; Seth A; Singh P; Mathur S; Sharma A
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2649-2661. PubMed ID: 31529191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells.
    Valla S; Hassan N; Vitale DL; Madanes D; Spinelli FM; Teixeira FCOB; Greve B; Espinoza-Sánchez NA; Cristina C; Alaniz L; Götte M
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.
    Golshani R; Lopez L; Estrella V; Kramer M; Iida N; Lokeshwar VB
    Cancer Res; 2008 Jan; 68(2):483-91. PubMed ID: 18199543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance.
    Bourguignon LYW; Earle C; Shiina M
    Matrix Biol; 2019 May; 78-79():180-200. PubMed ID: 30077625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression.
    Yu S; Cai X; Wu C; Wu L; Wang Y; Liu Y; Yu Z; Qin S; Ma F; Thiery JP; Chen L
    Oncotarget; 2015 Feb; 6(5):2951-65. PubMed ID: 25605020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan facilitates transforming growth factor-β1-dependent proliferation via CD44 and epidermal growth factor receptor interaction.
    Meran S; Luo DD; Simpson R; Martin J; Wells A; Steadman R; Phillips AO
    J Biol Chem; 2011 May; 286(20):17618-30. PubMed ID: 21454519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
    Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
    PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activation of ERK and Rac mediates the proliferative and anti-proliferative effects of hyaluronan and CD44.
    Kothapalli D; Flowers J; Xu T; Puré E; Assoian RK
    J Biol Chem; 2008 Nov; 283(46):31823-9. PubMed ID: 18806267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronan-CD44 interaction promotes growth of decidual stromal cells in human first-trimester pregnancy.
    Zhu R; Wang SC; Sun C; Tao Y; Piao HL; Wang XQ; Du MR; Da-Jin Li
    PLoS One; 2013; 8(9):e74812. PubMed ID: 24069351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1/2 via nAChR and beta-adrenoceptors in human bladder cancer cells.
    Chen RJ; Ho YS; Guo HR; Wang YJ
    Toxicol Sci; 2010 May; 115(1):118-30. PubMed ID: 20106947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression.
    Zhu H; Zhou W; Wan Y; Lu J; Ge K; Jia C
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.
    Bourguignon LY; Shiina M; Li JJ
    Adv Cancer Res; 2014; 123():255-75. PubMed ID: 25081533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism.
    Jeannot V; Busser B; Brambilla E; Wislez M; Robin B; Cadranel J; Coll JL; Hurbin A
    Int J Cancer; 2014 Jun; 134(11):2560-71. PubMed ID: 24374738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen Receptor Regulates CD44 Expression in Bladder Cancer.
    Sottnik JL; Vanderlinden L; Joshi M; Chauca-Diaz A; Owens C; Hansel DE; Sempeck C; Ghosh D; Theodorescu D
    Cancer Res; 2021 Jun; 81(11):2833-2846. PubMed ID: 33687952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 activation state regulated by the CD44v10 isoform determines breast cancer proliferation.
    Guo Q; Liu Y; He Y; Du Y; Zhang G; Yang C; Gao F
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
    Song JM; Im J; Nho RS; Han YH; Upadhyaya P; Kassie F
    Mol Carcinog; 2019 Mar; 58(3):321-333. PubMed ID: 30365189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of Hyaluronic acid-CD44 signaling pathway in cervical cancer cell by natural polyphenols Plumbagin, Pongapin and Karanjin.
    Roy R; Mandal S; Chakrabarti J; Saha P; Panda CK
    Mol Cell Biochem; 2021 Oct; 476(10):3701-3709. PubMed ID: 34081254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
    Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
    Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.
    Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q
    J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.